Literature DB >> 11499906

Do alcoholic liver transplantation candidates merit lower medical priority than non-alcoholic candidates?

W Martens1.   

Abstract

Alcoholic patients are frequently regarded as responsible for their alcoholism and alcohol-related diseases, such as liver damage. These patients run the risk of receiving lower medical priority for liver transplantation than patients who are considered as not responsible for their liver damage. However, hardly any scientific research findings support this supposed responsibility of the alcoholic patient for his addiction and the related diseases. Many alcoholic patients have comorbid psychiatric disorders such as antisocial personality disorder, schizophrenia and social phobia, and these cormorbid diseases are often linked specifically and also in a neurobiological way to alcohol abuse. Furthermore, concepts such as responsibility and health have multiple dimensions, which can be contrasted against each other. Useful and fair criteria are presented for the assessment of responsibility for our health.

Entities:  

Mesh:

Year:  2001        PMID: 11499906     DOI: 10.1007/s001470100306

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  3 in total

1.  Predictors of relapse to significant alcohol drinking after liver transplantation.

Authors:  Zamil Karim; Pongphob Intaraprasong; Charles H Scudamore; Siegfried R Erb; John G Soos; Elsie Cheung; Polly Cooper; Andrzej K Buzckowski; Stephen W Chung; Urs P Steinbrecher; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2010-04       Impact factor: 3.522

Review 2.  Ethical issues associated with solid organ transplantation and substance use: a scoping review.

Authors:  Lauren Notini; Denitsa Vasileva; Ani Orchanian-Cheff; Daniel Z Buchman
Journal:  Monash Bioeth Rev       Date:  2019-12

3.  Viewpoints among experts and the public in the Netherlands on including a lifestyle criterion in the healthcare priority setting.

Authors:  Charlotte M Dieteren; Vivian T Reckers-Droog; Sara Schrama; Dynothra de Boer; Job van Exel
Journal:  Health Expect       Date:  2021-11-29       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.